Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UBS Maintains Neutral on Oak Street Health, Lowers Price Target to $21

UBS Maintains Neutral on Oak Street Health, Lowers Price Target to $21

UBS analyst Andrew Mok maintains Oak Street Health (NYSE:OSH) with a Neutral and lowers the price target from $28 to $21.

January 6, 2023

1 minute read

UBS analyst Andrew Mok maintains Oak Street Health (NYSE:OSH) with a Neutral and lowers the price target from $28 to $21.

Wendy’s +3% After Q1 Results On Solid Growth In US Breakfast Sales Despite Labor Cost Issues

May 2, 11:22 AM

Wendy's shares rise 3% post-Q1 results driven by strong U.S. breakfast sales growth, while adjusted EPS beats expectations and dividend declared.

February 1, 12:00 PM

Flutter Entertainment (NYSE:FLUT) has outperformed the market over the past 5 years by 9.32% on an annualized basis…

January 12, 8:30 AM

Barclays analyst Leon Wang downgrades CinCor Pharma (NASDAQ:CINC) from Overweight to Equal-Weight and raises the price target from $22 to $31.

November 28, 7:26 AM

Jefferies analyst Johnson Wan downgrades XPeng (NYSE:XPEV) from Hold to Underperform and lowers the price target from $18.6 to $4.2.